Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide for Refractory Skin Henoch-Schonlein Purpura
NCT05937880Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jan 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of leflunomide in immunoglobulin A vasculitis, sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Rash frequency at 12 months. Started Jan 2023; status: recruiting.
02
Drugs
leflunomide
03
Conditions
immunoglobulin A vasculitis
Beyond the preview
Go deeper on NCT05937880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05937880.